MedPath

The effectiveness of a cognitive behavioral treatment with virtual reality for problem gambling

Not Applicable
Conditions
Treatment and relapse prevention for adults suffering from pathological gambling
Mental and Behavioural Disorders
Registration Number
ISRCTN16969130
Lead Sponsor
Fonds de Recherche du Québec - Société et culture
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
7
Inclusion Criteria

1. French speaking
2. At least 18 years old
3. Receiving a principal diagnosis of Pathological gambling based on DSM-5 diagnostic criteria. Assessed with a semi-structured diagnostic interview (EDJP-5)
4. Mainly play VLT
5. Having a goal of abstinence from gambling
6. Do not suffer from health problems that may be exacerbated by the VR treatment (e.g., intense and frequent discomfort during car trips, vestibular or inner ear disorders, recurrent migraines, epilepsy, partial or total blindness).
7. Do not suffer from a untreated mental health problem that may be contraindicated in VR (e.g., psychotic disorders, intellectual disability, bipolar affective illness).
8. Being able to travel to the Université du Québec en Outaouais

Exclusion Criteria

1. Do not speak French
2. Less than 18 years old
3. Do not have received a principal diagnosis of Pathological gambling based on DSM-5 diagnostic criteria. Assessed with a semi-structured diagnostic interview (EDJP-5)
4. Do not mainly play VLT
5. Do not have a goal of abstinence from gambling
6. Suffer from health problems that may be exacerbated by the VR treatment (e.g., intense and frequent discomfort during car trips, vestibular or inner ear disorders, recurrent migraines, epilepsy, partial or total blindness).
7. Suffer from a untreated mental health problem that may be contraindicated in VR (e.g., psychotic disorders, intellectual disability, bipolar affective illness).
8. Do not be able to travel to the Université du Québec en Outaouais

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Current primary outcome measure as of 11/03/2024:<br>Gambling Self Efficacy Questionnaire completed on a daily basis during the baseline and treatment phases.<br><br>Previous primary outcome measure:<br>Gambling Self Efficacy Questionnaire (GSEQ; May, Whelan Steenbergh & Meyers, 2003) at pre- and post-test as well as at 6- and 12-month follow-ups.
Secondary Outcome Measures
NameTimeMethod
1. Entrevue diagnostique sur le jeu pathologique-5 (EDJP-5): diagnostic interview at pre- and post-test as well as at 6- and 12-months follow-ups.<br>2. Gambling Craving Scale (GACS; Young & Wohl, 2009): at pre- and pos-test as well as at 6- and 12-months follow-ups.<br>3. Information Biases Scale (IBS; Jefferson & Nicki, 2003): at pre- and pos-test as well as at 6- and 12-months follow-ups.<br>4. Experience lived during the exposure measured using Questionnaire d’attentes envers l’exposition (QAE; Bergeron, Giroux et Bouchard, 2019): before and after each exposure. <br>5. Cybersickness symptoms measured using Simulator Sickness Questionnaire (QC; Kennedy, Lane, Berbaum, & Lilienthal, 1993; Bouchard et al., 2011): before and after each exposure in virtual reality.
© Copyright 2025. All Rights Reserved by MedPath